DEFINITIVE PROXY STATEMENT

Company

NEKTAR THERAPEUTICS

Filed

April 14, 2005

Period of Report

June 2, 2005

Accession Number

0001193125-05-076585

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →